Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03712553 · ClinicalTrials.gov registry record · NA
Behavioral Science and Hepatitis C Screening Outreach
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 21,493
- Enrollment target
NCT03712553: Completed NA study, sponsored by University of Pennsylvania.
NCT03712553 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 21,493 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1432% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03712553, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 21,493 participants
- Enrollment target
Study Summary
This project aims to evaluate different approaches to increase Hepatitis C screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, we will evaluate different approaches to increase completion of screening among eligible patients, including changing the default from opt-in to opt-out and incorporating behavioral science principles into the outreach communication.
Primary Outcome
Percentage of patients who complete HCV antibody testing within 4 months of initial outreach
Interventions
- BEHAVIORAL Letter
- BEHAVIORAL Opt-Out
- BEHAVIORAL Behavioral Economic Messaging
- BEHAVIORAL Usual Care Messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,493 participants |
| Start Date | 2019-03-15 |
| Est. Completion | 2020-10-15 |
| Phase | NA |
What the finished NCT03712553 record still lists
NCT03712553 is an interventional study that assigns participants to a tested intervention. Its 21,493 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1432% higher).
The record links to 0 conditions, and to 4 interventions - of which Letter is the first listed.
NCT03712553 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03712553 about?
NCT03712553 is a clinical study titled "Behavioral Science and Hepatitis C Screening Outreach". This project aims to evaluate different approaches to increase Hepatitis C screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, we will evaluate different approaches to increase completion of screening among eligible patients,...
What is the current status of trial NCT03712553?
This trial is currently completed. It is a NA study. The enrollment target is 21,493 participants. The study started on 2019-03-15. Estimated completion is 2020-10-15.
What interventions are being tested in trial NCT03712553?
The interventions under investigation include: Letter (BEHAVIORAL), Opt-Out (BEHAVIORAL), Behavioral Economic Messaging (BEHAVIORAL), Usual Care Messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT03712553?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03712553's enrollment target sits among peer trials
21,493 10th of 2000 higher than 1,991 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06047041 · 21,350 participants · NA
Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students
- NCT07213531 · 21,000 participants
Enhanced Valves Interventions and Safe AI Generated End Results
- NCT05832307 · 22,000 participants · NA
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
- NCT05488080 · 22,032 participants · NA
PAINED: Project Addressing INequities in the Emergency Department
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI